|
BRPI0510284A
(pt)
|
2004-05-12 |
2007-10-30 |
Pfizer Prod Inc |
derivados de prolina e seu uso como inibidores da dipeptidil peptidase iv
|
|
CA2598365A1
(en)
*
|
2005-02-18 |
2006-11-16 |
Innodia Inc. |
Analogs of 4-hydroxyisoleucine and uses thereof
|
|
CA2600954A1
(en)
*
|
2005-03-22 |
2006-12-14 |
Innodia Inc. |
Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
|
|
EP1888562B1
(en)
|
2005-04-22 |
2014-06-18 |
Alantos Pharmaceuticals Holding, Inc. |
Dipeptidyl peptidase-iv inhibitors
|
|
CA2617715A1
(en)
*
|
2005-08-11 |
2007-02-15 |
F. Hoffmann-La Roche Ag |
Pharmaceutical composition comprising a dpp-iv inhibitor
|
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
|
US20100048545A1
(en)
*
|
2006-03-22 |
2010-02-25 |
Innodia Inc. |
Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
US7727978B2
(en)
*
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
GB0713602D0
(en)
*
|
2007-07-12 |
2007-08-22 |
Syngenta Participations Ag |
Chemical compounds
|
|
GB2465132B
(en)
*
|
2007-09-21 |
2012-06-06 |
Lupin Ltd |
Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors
|
|
JP5305704B2
(ja)
*
|
2008-03-24 |
2013-10-02 |
富士フイルム株式会社 |
新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
|
|
EP2108960A1
(en)
|
2008-04-07 |
2009-10-14 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
|
|
GB2483614B
(en)
|
2009-06-18 |
2014-12-03 |
Lupin Ltd |
2-Amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
|
|
US8999975B2
(en)
*
|
2011-09-19 |
2015-04-07 |
Boehringer Ingelheim International Gmbh |
Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
|
|
SI2822954T1
(sl)
|
2012-12-21 |
2016-07-29 |
Gilead Sciences, Inc. |
Policiklične karbamoilpiridonske spojine in njihova farmacevtska uporaba
|
|
GEP201706780B
(en)
|
2013-03-14 |
2017-11-27 |
Boehringer Ingelheim Int |
Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
|
|
WO2014140091A1
(en)
|
2013-03-14 |
2014-09-18 |
Boehringer Ingelheim International Gmbh |
Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
|
|
NO2865735T3
(enExample)
|
2013-07-12 |
2018-07-21 |
|
|
|
PT3019503T
(pt)
|
2013-07-12 |
2017-11-27 |
Gilead Sciences Inc |
Compostos carbamoílpiridona- policíclicos e seu uso para o tratamento de infecções por hiv
|
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
|
NO2717902T3
(enExample)
|
2014-06-20 |
2018-06-23 |
|
|
|
TWI744723B
(zh)
|
2014-06-20 |
2021-11-01 |
美商基利科學股份有限公司 |
多環型胺甲醯基吡啶酮化合物之合成
|
|
JP6529575B2
(ja)
|
2014-08-01 |
2019-06-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
置換オキセタンおよびそれらのカテプシンｃの阻害薬としての使用
|
|
UA118610C2
(uk)
|
2014-09-12 |
2019-02-11 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Спіроциклічні інгібітори катепсину c
|
|
TWI695003B
(zh)
|
2014-12-23 |
2020-06-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
|
MX386778B
(es)
|
2015-03-09 |
2025-03-19 |
Intekrin Therapeutics Inc |
Métodos para el tratamiento de enfermedad de hígado graso no alcohólico y/o lipodistrofia.
|
|
WO2016161382A1
(en)
|
2015-04-02 |
2016-10-06 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
|
WO2018187350A1
(en)
|
2017-04-03 |
2018-10-11 |
Coherus Biosciences Inc. |
PPARγ AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY
|
|
IT201700059292A1
(it)
|
2017-05-31 |
2018-12-01 |
Univ Pisa |
Derivati 1,3-diaza-4-ossa-[3.3.1]-biciclici, loro preparazione e uso come medicinale, in particolare per il trattamento del diabete
|
|
US20210198283A1
(en)
|
2018-08-08 |
2021-07-01 |
Sumitomo Dainippon Pharma Co., Ltd. |
Optically active bridged piperidine derivative
|
|
EA202190623A1
(ru)
|
2018-08-27 |
2021-05-21 |
Сумитомо Дайниппон Фарма Ко., Лтд. |
Оптически активное азабициклическое производное
|